Page 20 - GPD-4-3
P. 20

Gene & Protein in Disease                                      Targeting cathepsins during cancer development



            10.  Turk B, Turk D, Turk V. Lysosomal cysteine proteases: More than   protease zymogen. J Mol Biol. 1997;271(5):774-788.
               scavengers. Biochim Biophys Acta. 2000;1477(1-2):98-111.
                                                                  doi: 10.1006/jmbi.1997.1218
               doi: 10.1016/s0167-4838(99)00263-0
                                                               21.  Renko M, Pozgan U, Majera D, Turk D. Stefin A displaces the
            11.  Soond SM, Zamyatnin AA Jr. Helicobacter pylori and gastric   occluding loop of cathepsin B only by as much as required to
               cancer: A  lysosomal protease perspective.  Gastric Cancer.   bind to the active site cleft. FEBS J. 2010;277(20):4338-4345.
               2022;25(2):306-324.
                                                                  doi: 10.1111/j.1742-4658.2010.07824.x
               doi: 10.1007/s10120-021-01272-8
                                                               22.  Cory S, Adams JM. The Bcl2 family: Regulators of the cellular
            12.  Soond SM, Kozhevnikova MV, Savvateeva LV, Townsend PA,   life-or-death switch. Nat Rev Cancer. 2002;2(9):647-656.
               Zamyatnin AA Jr. Intrinsically connected: Therapeutically
               targeting the cathepsin proteases and the Bcl-2 family of      doi: 10.1038/nrc883
               protein substrates as co-regulators of apoptosis. Int J Mol Sci.   23.  Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins
               2021;22(9):4669.                                   and caspases in the regulation of apoptosis.  Mol Cell
                                                                  Biochem. 2011;351(1-2):41-58.
               doi: 10.3390/ijms22094669
            13.  De Castro MA, Bunt G, Wouters FS. Cathepsin B launches      doi: 10.1007/s11010-010-0709-x
               an apoptotic exit effort upon cell death-associated disruption   24.  Garcia-Saez AJ. The secrets of the Bcl-2 family. Cell Death
               of lysosomes. Cell Death Discov. 2016;2:16012.     Differ. 2012;19(11):1733-1740.
               doi: 10.1038/cddiscovery.2016.12                   doi: 10.1038/cdd.2012.105
            14.  Turk B, Dolenc I, Turk V, Bieth JG, Kinetics of the   25.  Youle RJ, Strasser A. The BCL-2 protein family: Opposing
               pH-induced inactivation of human cathepsin L.      activities  that mediate  cell  death.  Nat Rev Mol Cell Biol.
               Biochemistry. 1993;32(1):375-380.                  2008;9(1):47-59.
               doi: 10.1021/bi00052a046                           doi: 10.1038/nrm2308
            15.  Turk B, Bieth JG, Bjork I, et al. Regulation of the activity of   26.  Huang DC, Adams JM, Cory S. The conserved N-terminal
               lysosomal cysteine proteinases by pH-induced inactivation   BH  domain of Bcl-2 homologues is essential for inhibition
                                                                     4
               and/or endogenous protein inhibitors, cystatin. Biol Chem   of apoptosis and interaction with CED-4.  EMBO  J.
               Hoppe Seyler. 1995;376(4):225-230.                 1998;17(4):1029-1039.
               doi: 10.1515/bchm3.1995.376.4.225                  doi: 10.1093/emboj/17.4.1029
            16.  Edgington LE, Verdoes M, Bogyo M. Functional imaging of   27.  Kvansakul M, Yang H, Fairlie WD, et al. Vaccinia virus anti-
               proteases: Recent advances in the design and application of   apoptotic F1L is a novel Bcl-2-like domain-swapped dimer
               substrate-based and activity-based probes. Curr Opin Chem   that binds a highly selective subset of BH3-containing death
               Biol. 2011;15(6):798-805.                          ligands. Cell Death Differ. 2008;15(10):1564-1571.
               doi: 10.1016/j.cbpa.2011.10.012                    doi: 10.1038/cdd.2008.83
            17.  Jain M, Bouilloux J, Borrego I, et al. Cathepsin B-cleavable   28.  Townsend  PA,  Kozhevnikova  MV,  Cexus  ONF,
               polymeric  photosensitizer  prodrug  for  selective  Zamyatnin  AA Jr., Soond  SM. BH3-mimetics:  Recent
               photodynamic therapy:  In vitro studies.  Pharmaceuticals   developments in cancer therapy. J  Exp Clin Cancer Res.
               (Basel). 2022;15(5):564.                           2021;40(1):355.
               doi: 10.3390/ph15050564
                                                                  doi: 10.1186/s13046-021-02157-5
            18.  Chowdhury  MA,  Moya  IA, Bhilocha  S, et al.  Prodrug-  29.  Lomonosova E, Chinnadurai G. BH3-only proteins
               inspired probes selective to cathepsin B over other cysteine   in apoptosis and beyond: An overview.  Oncogene.
               cathepsins. J Med Chem. 2014;57(14):6092-6104.
                                                                  2008;27(Suppl 1):S2-S19.
               doi: 10.1021/jm500544p
                                                                  doi: 10.1038/onc.2009.39
            19.  Soond  SM,  Kozhevnikova  MV,  Townsend  PA,  30.  Flores-Romero H, Ros U, Garcia-Saez AJ. Pore formation in
               Zamyatnin AA Jr. Cysteine cathepsin protease inhibition:   regulated cell death. EMBO J. 2020;39(23):e105753.
               An update on its diagnostic, prognostic and therapeutic
               potential in cancer. Pharmaceuticals (Basel). 2019;12(2):87.     doi: 10.15252/embj.2020105753
               doi: 10.3390/ph12020087                         31.  Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-
                                                                  dependent formation of Apaf-1/caspase-9 complex initiates
            20.  Podobnik M, Kuhelj R, Turk V, Turk D. Crystal structure
               of the wild-type human procathepsin B at 2.5 A resolution   an apoptotic protease cascade. Cell. 1997;91(4):479-489.
               reveals the native active site of a papain-like cysteine      doi: 10.1016/s0092-8674(00)80434-1


            Volume 4 Issue 3 (2025)                         9                               doi: 10.36922/gpd.4768
   15   16   17   18   19   20   21   22   23   24   25